CDEK
← All drugs Report issue

hlx208

Small moleculeexperimental

Clinical trial activity

12 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
9
Phase 3
0
Phase 4
0

Earliest trial started Aug 11, 2021 (NCT04984369)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05902728Phase 1Jul 4, 2023Shanghai Henlius Biotech
NCT05841940Phase 1Jul 1, 2023Shanghai Henlius Biotech, Soochow University
NCT05641493Phase 1/Phase 2 (Phase 2)Dec 7, 2022Shanghai Henlius Biotech
NCT05528406Phase 2Oct 20, 2022Shanghai Henlius Biotech
NCT05127759Phase 2Jan 15, 2022Shanghai Henlius Biotech
NCT05114603Phase 2Nov 30, 2021Shanghai Henlius Biotech
NCT05092802Phase 2Nov 26, 2021Shandong first medical University, Shanghai Henlius Biotech
NCT05102292Phase 1/Phase 2 (Phase 2)Nov 15, 2021Shanghai Henlius Biotech
NCT05065398Phase 2Nov 15, 2021Shanghai Henlius Biotech
NCT05092815Phase 2Nov 10, 2021Shanghai Henlius Biotech
NCT04965220Phase 1Sep 15, 2021Shanghai Henlius Biotech
NCT04984369Phase 2Aug 11, 2021Shanghai Henlius Biotech
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shanghai Henlius BiotechFor profit121222021
Shandong first medical UniversityAcademic/Hospital1012021
Soochow UniversityAcademic/Hospital1012023
3 organizations
Page 1 / 1